GENEVA, Feb. 17 -- OTSUKA PHARMACEUTICAL CO., LTD. (2-9, Kanda Tsukasa-machi, Chiyoda-ku, Tokyo1018535), 大塚製薬株式会社 (東京都千代田区神田司町２丁目９番地) filed a patent application (PCT/JP2025/028328) for "TAU SPLICE-SWITCHING OLIGONUCLEOTIDE AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING TAU-RELATED DISEASE" on Aug 08, 2025. With publication no. WO/2026/034630, the details related to the patent application was published on Feb 12, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intel...